68Ga-FAPI PET/CT in Malignant Tumors

Clinical trial NCT05034146 · RECRUITING

Trial details

NCT number: NCT05034146
Sponsor: Zhongnan Hospital
Status: RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

Fibroblast Activation Protein Inhibitor PET/CT Malignant Neoplasm

Start date: 2021-02-23
Primary completion: 2025-12-31
Enrollment: 500

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.